FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Zydus Pharmaceuticals Pramipexole Dihydrochloride Tablets 1 Recall

Pramipexole Dihydrochloride Tablets 1

Zydus Pharmaceuticals USA Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Jun 26, 2019
Recall ID
D-1452-2019
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals recalled Pramipexole Dihydrochloride Tablets 1 starting May 6, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1452-2019 on Jun 26, 2019. Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. Status: Terminated.

Why it was recalled

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Product description

Pramipexole Dihydrochloride Tablets 1.5 mg 90-count bottle, Rx only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ NDC 68382-200-16

Lot numbers, UPCs & expiration codes

Lots: M713435 M713436 EXP Sep-19; M714191 EXP Oct-19; M808185 M808184 M808186 EXP May-20; M817634 M817635 EXP Nov-20

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1452-2019
Classification
Class II
Status
Terminated
Recall initiated
May 6, 2019
FDA report date
Jun 26, 2019
Quantity
47,664 90-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-1452-2019, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
82827
Address
73 Route 31 N
Code information
Lots: M713435 M713436 EXP Sep-19; M714191 EXP Oct-19; M808185 M808184 M808186 EXP May-20; M817634 M817635 EXP Nov-20
Postal code
08534-3601
Report date
Jun 26, 2019
Product type
Drugs
Recall number
D-1452-2019
Classification
Class II
Recalling firm
Zydus Pharmaceuticals USA Inc
Product quantity
47,664 90-count bottles
Termination date
Sep 16, 2021
Reason for recall
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pramipexole Dihydrochloride Tablets 1.5 mg 90-count bottle, Rx only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ NDC 68382-200-16
Distribution pattern
Nationwide in the USA
Recall initiation date
May 6, 2019
Initial firm notification
Letter
Center classification date
Jul 1, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1452-2019, published Jun 26, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls